23%OFF
The Biotech Investor's Bible
George Wolff
€ 46.99
€ 36.10
FREE Delivery in Ireland
Description for The Biotech Investor's Bible
Hardcover. A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. Num Pages: 336 pages, Ill. BIC Classification: KFFL; KFFM; TCB. Category: (G) General (US: Trade); (P) Professional & Vocational. Dimension: 236 x 162 x 29. Weight in Grams: 582.
A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries
To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle ... Read more
Show LessProduct Details
Format
Hardback
Publication date
2001
Publisher
John Wiley and Sons Ltd United States
Number of pages
336
Condition
New
Number of Pages
336
Place of Publication
New York, United States
ISBN
9780471412793
SKU
V9780471412793
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50
About George Wolff
GEORGE WOLFF is an award-winning journalist and, currently, a private business consultant to several firms in the investment industry. He has assessed and reported on more than 200 biotechnology companies for his clientele, issuing a number of valuable white papers charting the emergence of biotechnology. Previously, as a journalist, Wolff worked internationally covering the onset of the AIDS epidemic, the ... Read more
Reviews for The Biotech Investor's Bible